LINC02763

Across TCGA pan-cancer cohorts, LINC02763 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02763’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02763 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02763 is over-expressed in tumor, although a few such as BRCA and BLCA show the opposite, repressed pattern.

HNSC, LUSC, and CHOL are the cancer types where LINC02763 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02763 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.352	.001	10	view →
LUSC	All	All	+0.303	<.001	4	view →
CHOL	All	All	+0.371	.026	2	view →
BRCA	All	III,IV	−0.055	.004	2	view →
BLCA	Male	IV	−0.112	.031	1	view →
KIRC	All	IV	+0.062	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02763–HNSC

Open the HNSC breakdown →